|
Diaz-Carrasco MS, Sanchez-Salinas A, Fernandez-Avila JJ, Olmos-Jimenez R, Espanol-Morales I, Espuny-Miro A. Prospective observational study of oral clonazepam to prevent high-dose busulfan-induced seizures in adult patients. J Egypt Natl Canc Inst. 2025 Feb 3;37(1):4. doi: 10.1186/s43046-025-00257-3. PubMed PMID: 39894848.
AÑO: 2025
|
39894848
|
Pons-Fuster E, Gonzalez-Ponce CM, Ros-Martinez S, Fernandez-Avila JJ, Diaz-Carrasco MS, Espuny-Miro A. Real-world clinical outcomes of apalutamide versus abiraterone with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. Int J Clin Pharm. 2025 May 6. doi: 10.1007/s11096-025-01920-4. Online ahead of print. PubMed PMID: 40327314.
AÑO: 2025; IF: 2.6
|
|
Ramirez-Roig C, Espuny-Miro A, Olmos-Jimenez R, Diaz-Carrasco MS. Carboplatin dosing in obese patients. J Oncol Pharm Pract. 2024 Nov 4:10781552241292503. doi: 10.1177/10781552241292503. Online ahead of print. PubMed PMID: 39497478.
AÑO: 2024; IF: 1.0
|
|
Saez-Garrido M, Espuny-Miro A, Ruiz-Gomez A, Diaz-Carrasco MS. Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review. Farm Hosp. 2021 Jun 3;45(4):184-192. doi: 10.7399/fh.11627. PubMed PMID: 34218764.
AÑO: 2021
|
|
Diaz-Carrasco MS, Gonzalez-Haba E, Garcia-Soler JI, Espuny-Miro A. Predictive biomarkers of response to immune checkpoint inhibitors. Farm Hosp. 2020 Jul 1;44(4):141-148. doi: 10.7399/fh.11328. PubMed PMID: 32646345.
AÑO: 2020
|